A once-weekly injection for weight loss known as a ‘GP-1 agonist’. It mimics a hormone in the gut that reduces our desire to eat and controls sugar in the blood. Developed originally for diabetes but ...

The chain says tirzepatide injections, sold under the brand name Mounjaro, can help users shed up to 20 per cent of their ...

Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.